Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors. [electronic resource]
Producer: 20040927Description: 662-72 p. digitalISSN:- 0008-6363
- Adrenergic Antagonists -- pharmacology
- Calcium -- metabolism
- Carbazoles -- pharmacology
- Carvedilol
- Cell Line
- Humans
- Kidney -- embryology
- Mitogen-Activated Protein Kinases -- metabolism
- Norepinephrine -- pharmacology
- Phenylephrine -- pharmacology
- Propanolamines -- pharmacology
- Protein Binding
- Receptors, Adrenergic, alpha-1 -- metabolism
- Receptors, Adrenergic, beta -- metabolism
- Stimulation, Chemical
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.